Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial (2019)
- Authors:
- Autor USP: BOCCHI, EDIMAR ALCIDES - FM
- Unidade: FM
- DOI: 10.1002/ejhf.1536
- Subjects: INSUFICIÊNCIA CARDÍACA; PROTEÍNAS DE TRANSPORTE; MORBIDADE; DIABETES MELLITUS NÃO INSULINO-DEPENDENTE; GLICOSÍDEOS
- Language: Inglês
- Imprenta:
- Source:
- Título: European journal of heart failure
- ISSN: 1388-9842
- Volume/Número/Paginação/Ano: v. 21, n. 10, p. 1270-1278, 2019
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc
-
ABNT
PACKER, Milton et al. Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial. European journal of heart failure, v. 21, n. 10, p. 1270-1278, 2019Tradução . . Disponível em: https://doi.org/10.1002/ejhf.1536. Acesso em: 14 nov. 2024. -
APA
Packer, M., Butler, J., Filippatos, G. S., Jamal, W., Salsali, A., Schnee, J., et al. (2019). Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial. European journal of heart failure, 21( 10), 1270-1278. doi:10.1002/ejhf.1536 -
NLM
Packer M, Butler J, Filippatos GS, Jamal W, Salsali A, Schnee J, Kimura K, Zeller C, George J, Bocchi EA. Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial [Internet]. European journal of heart failure. 2019 ; 21( 10): 1270-1278.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/ejhf.1536 -
Vancouver
Packer M, Butler J, Filippatos GS, Jamal W, Salsali A, Schnee J, Kimura K, Zeller C, George J, Bocchi EA. Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial [Internet]. European journal of heart failure. 2019 ; 21( 10): 1270-1278.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/ejhf.1536 - Diagnóstico não invasivo de rejeição em transplante cardíaco: utilização de modelo com alta sensibilidade pelo doppler tecidual
- The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy Quo Vadis?
- Coronary flow reserve impairment predicts cardiac events in heart transplant patients with preserved left ventricular function
- Recomdendations for use of everolimus after heart transplantation: results from a latin-american consensus meeting
- Cardiomiopatia dilatada
- Cardiomyopathy, adult valve disease and heart failure in South America
- Cirurgia cardíaca e transplante
- Reproducibility of the self-controlled six-minute walking test in heart failure patients
- Redução da Prevalência de Apneia Central em Pacientes com Insuficiência Cardíaca sob Uso de Betabloqueador
- Quimiossensibilidade durante exercício na insuficiência cardíaca: respostas ventilatórias, cronotrópicas e neurohormonais
Informações sobre o DOI: 10.1002/ejhf.1536 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
